Role of Intestinal Microbiota in Ulcerative Colitis

Role of Intestinal Microbiota in Ulcerative Colitis Role of Intestinal Microbiota in Ulcerative Colitis

05.02.2013 Views

layer of UC patients and found that the mucus layer of the left colon and rectum was significantly thinner in the UC patients compared to the control group, and that areas of acute inflamed mucosa were denuded of mucus layer. It has previously been hypothesized that Akk. muciniphila could be a causal factor for intestinal inflammation, since its presence leads to degradation of the protective mucin layer [12,58]; however, our observations contradict this hypothesis. Lactobacillus spp. was significantly less abundant in fecal microbiota of UC patients in relapse than in that of healthy controls (Table 3). To our knowledge, this has not previously been reported. Species of Lactobacillus, although constituting less than 2% of the total intestinal population, are considered to be beneficial commensal enteric bacteria and have, accordingly, been shown to exert anti‐inflammatory effects [36,43,50,57]. Animal studies using probiotic strains have shown that certain lactobacilli down regulate pro‐inflammatory cytokines, prevent chemical‐induced colonic damage and reduce colonic permeability [25,36,37]. Additionally, a previous study has shown, that increased levels of lactobacilli can help maintain remission in UC patients [59]. Hence, the reduced content of Lactobacillus spp. in UC patients in relapse could have contributed to the flare‐up, or alternatively these populations may have been reduced as a consequence of the inflammatory condition. To address this issue, long term studies, where patients are followed regularly in order to detect subtle changes in the intestinal microbiota prior to development of symptoms clinical activity, are needed. A reduced level of the C. leptum subgroup (include potentially important butyrate producers) has previously been suggested to play a role in the onset of IBD flare‐ups [51,52]. The protective role of C. leptum subgroup could be through their ability to induce regulatory T cells in the colon and through their metabolite, butyrate that can down regulate pro‐inflammatory cytokine production via inhibition of NF‐κβ. Both mechanisms stimulate an anti‐inflammatory state in the colon [4,17,46]. However, possibly because of the relatively low number of patients investigated, we found no differences in the density of C. leptum subgroup between the three groups of subjects included in the present study. Nevertheless, there was a trend that the C. leptum subgroup was less abundant in UC patients in remission (P=0.08) as well as in those with relapse (P=0.09) compared to controls. A recent metagenomic study has demonstrated the existence of enterotypes in the human gut microbiome and identified three of them that varied in species and functional composition. Each 12

of the enterotypes was formed by three distinct clusters. Two of these clusters are rich in Bacteroides and Prevotella (enterotype 1 and enterotype 2, respectively), whereas the third cluster is richer than enterotype 1 and enterotype 2 in Ruminococcus (Clostridiales order), Alistipes and Akk. muciniphila (enterotype 3) [3]. The present study demonstrated a predominance of Bacteroides spp. and Prevotella spp. in UC patients in relapse and a predominance of the C. leptum subgroup, Akk. muciniphila and Lactobacillus spp. in the healthy controls (Figure 1 and Table 2). This suggests that the enterotypes could be correlated with UC risk of individuals. Bifidobacterium spp. are believed to play an important role in maintaining intestinal health [24,31,34]. In our study, B. bifidum was completely absent in the UC patients in relapse, while frequently occurring in the other groups. Previous in vitro studies have shown that several strains of bifidobacteria, with B. bifidum being most effective, have an antagonistic potential on LPS‐ induced inflammatory responses by blocking NF‐κB activation in intestinal epithelial cells [16,42,49]. Hence, a reduced level of B. bifidum and an altered composition of the Gram‐negative bacteria in UC patients in relapse compared to healthy controls, as observed in this study, may favor intestinal inflammation. Conclusions Based on the results presented within this study, we conclude that UC patients in relapse appear to have a different fecal microbiota than healthy controls and this difference could be ascribed to the Gram‐negative bacteria, especially members of the Bacteroidetes phylum and Akk. muciniphila. Some samples from patients in remission resemble those of patients in relapse, while others resemble those of the healthy controls, indicating that the microbiota is unstable and perhaps changes during the remission period, which, in theory, may contribute to provoke a new flare‐up. Our findings indicate that an alteration in the composition of the Gram‐negative bacteria and a reduction of the beneficial Gram‐positive bacteria lactobacilli and B. bifidum plays a role in provoking flare‐ups in UC, but do not prove whether the observed changes are causal to or rather results from the relapse condition. Further longitudinal studies are warranted to extend the present findings and address this issue. 13

layer <strong>of</strong> UC patients and found that the mucus layer <strong>of</strong> the left colon and rectum was significantly<br />

th<strong>in</strong>ner <strong>in</strong> the UC patients compared to the control group, and that areas <strong>of</strong> acute <strong>in</strong>flamed<br />

mucosa were denuded <strong>of</strong> mucus layer. It has previously been hypothesized that Akk. muc<strong>in</strong>iphila<br />

could be a causal factor for <strong>in</strong>test<strong>in</strong>al <strong>in</strong>flammation, s<strong>in</strong>ce its presence leads to degradation <strong>of</strong> the<br />

protective muc<strong>in</strong> layer [12,58]; however, our observations contradict this hypothesis.<br />

Lactobacillus spp. was significantly less abundant <strong>in</strong> fecal microbiota <strong>of</strong> UC patients <strong>in</strong> relapse than<br />

<strong>in</strong> that <strong>of</strong> healthy controls (Table 3). To our knowledge, this has not previously been reported.<br />

Species <strong>of</strong> Lactobacillus, although constitut<strong>in</strong>g less than 2% <strong>of</strong> the total <strong>in</strong>test<strong>in</strong>al population, are<br />

considered to be beneficial commensal enteric bacteria and have, accord<strong>in</strong>gly, been shown to<br />

exert anti‐<strong>in</strong>flammatory effects [36,43,50,57]. Animal studies us<strong>in</strong>g probiotic stra<strong>in</strong>s have shown<br />

that certa<strong>in</strong> lactobacilli down regulate pro‐<strong>in</strong>flammatory cytok<strong>in</strong>es, prevent chemical‐<strong>in</strong>duced<br />

colonic damage and reduce colonic permeability [25,36,37]. Additionally, a previous study has<br />

shown, that <strong>in</strong>creased levels <strong>of</strong> lactobacilli can help ma<strong>in</strong>ta<strong>in</strong> remission <strong>in</strong> UC patients [59]. Hence,<br />

the reduced content <strong>of</strong> Lactobacillus spp. <strong>in</strong> UC patients <strong>in</strong> relapse could have contributed to the<br />

flare‐up, or alternatively these populations may have been reduced as a consequence <strong>of</strong> the<br />

<strong>in</strong>flammatory condition. To address this issue, long term studies, where patients are followed<br />

regularly <strong>in</strong> order to detect subtle changes <strong>in</strong> the <strong>in</strong>test<strong>in</strong>al microbiota prior to development <strong>of</strong><br />

symptoms cl<strong>in</strong>ical activity, are needed.<br />

A reduced level <strong>of</strong> the C. leptum subgroup (<strong>in</strong>clude potentially important butyrate producers) has<br />

previously been suggested to play a role <strong>in</strong> the onset <strong>of</strong> IBD flare‐ups [51,52]. The protective role<br />

<strong>of</strong> C. leptum subgroup could be through their ability to <strong>in</strong>duce regulatory T cells <strong>in</strong> the colon and<br />

through their metabolite, butyrate that can down regulate pro‐<strong>in</strong>flammatory cytok<strong>in</strong>e production<br />

via <strong>in</strong>hibition <strong>of</strong> NF‐κβ. Both mechanisms stimulate an anti‐<strong>in</strong>flammatory state <strong>in</strong> the colon<br />

[4,17,46]. However, possibly because <strong>of</strong> the relatively low number <strong>of</strong> patients <strong>in</strong>vestigated, we<br />

found no differences <strong>in</strong> the density <strong>of</strong> C. leptum subgroup between the three groups <strong>of</strong> subjects<br />

<strong>in</strong>cluded <strong>in</strong> the present study. Nevertheless, there was a trend that the C. leptum subgroup was<br />

less abundant <strong>in</strong> UC patients <strong>in</strong> remission (P=0.08) as well as <strong>in</strong> those with relapse (P=0.09)<br />

compared to controls.<br />

A recent metagenomic study has demonstrated the existence <strong>of</strong> enterotypes <strong>in</strong> the human gut<br />

microbiome and identified three <strong>of</strong> them that varied <strong>in</strong> species and functional composition. Each<br />

12

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!